| The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10 S Abel, C Hundhausen, R Mentlein, A Schulte, TA Berkhout, N Broadway, ... The Journal of Immunology 172 (10), 6362-6372, 2004 | 515 | 2004 |
| Hematogenous dissemination of glioblastoma multiforme C Müller, J Holtschmidt, M Auer, E Heitzer, K Lamszus, A Schulte, ... Science translational medicine 6 (247), 247ra101-247ra101, 2014 | 325 | 2014 |
| Engineering NK cells modified with an EGFRvIII-specific chimeric antigen receptor to overexpress CXCR4 improves immunotherapy of CXCL12/SDF-1α-secreting glioblastoma N Müller, S Michen, S Tietze, K Töpfer, A Schulte, K Lamszus, M Schmitz, ... Journal of Immunotherapy 38 (5), 197-210, 2015 | 228 | 2015 |
| Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes C Hundhausen, A Schulte, B Schulz, MG Andrzejewski, N Schwarz, ... The Journal of Immunology 178 (12), 8064-8072, 2007 | 215 | 2007 |
| Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells A Ludwig, A Schulte, C Schnack, C Hundhausen, K Reiss, N Brodway, ... Journal of neurochemistry 93 (5), 1293-1303, 2005 | 152 | 2005 |
| Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells A Kathagen, A Schulte, G Balcke, HS Phillips, T Martens, J Matschke, ... Acta neuropathologica 126, 763-780, 2013 | 132 | 2013 |
| Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation A Kathagen-Buhmann, A Schulte, J Weller, M Holz, C Herold-Mende, ... Neuro-oncology 18 (9), 1219-1229, 2016 | 128 | 2016 |
| A distinct subset of glioma cell lines with stem cell‐like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target A Schulte, HS Günther, HS Phillips, D Kemming, T Martens, S Kharbanda, ... Glia 59 (4), 590-602, 2011 | 123 | 2011 |
| Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab M Voigt, F Braig, M Göthel, A Schulte, K Lamszus, C Bokemeyer, M Binder Neoplasia 14 (11), 1023-IN3, 2012 | 122 | 2012 |
| A novel fluorescent pH probe for expression in plants A Schulte, I Lorenzen, M Böttcher, C Plieth Plant methods 2, 1-13, 2006 | 112 | 2006 |
| Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by α-and γ-secretases A Schulte, B Schulz, MG Andrzejewski, C Hundhausen, S Mletzko, ... Biochemical and biophysical research communications 358 (1), 233-240, 2007 | 105 | 2007 |
| Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin F Scholz, A Schulte, F Adamski, C Hundhausen, J Mittag, A Schwarz, ... Journal of Investigative Dermatology 127 (6), 1444-1455, 2007 | 96 | 2007 |
| Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ A Schulte, K Liffers, A Kathagen, S Riethdorf, S Zapf, A Merlo, K Kolbe, ... Neuro-oncology 15 (10), 1289-1301, 2013 | 88 | 2013 |
| Glioblastoma stem–like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration A Schulte, HS Günther, T Martens, S Zapf, S Riethdorf, C Wülfing, ... Clinical Cancer Research 18 (7), 1901-1913, 2012 | 82 | 2012 |
| Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer BM Braig F, März M, Schieferdecker A, Schulte A, Voigt M, Stein A, Grob T ... Oncotarget 6 (14), 2015 | 66 | 2015 |
| Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer F Braig, M März, A Schieferdecker, A Schulte, M Voigt, A Stein, T Grob, ... Oncotarget, 2015 | 66 | 2015 |
| Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies M Preukschas, C Hagel, A Schulte, K Weber, K Lamszus, H Sievert, ... Public Library of Science 7 (8), e43468, 2012 | 66 | 2012 |
| RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant C Eckerich, A Schulte, T Martens, S Zapf, M Westphal, K Lamszus Journal of neurochemistry 109 (4), 969-980, 2009 | 59 | 2009 |
| EGFR amplification and glioblastoma stem-like cells K Liffers, K Lamszus, A Schulte, A Schulte Stem Cells International, 2015 | 55 | 2015 |
| PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression I Hohensee, HN Chuang, A Grottke, S Werner, A Schulte, S Horn, ... Oncotarget 8 (4), 6155, 2017 | 43 | 2017 |
Glatzel, MProfessor of Neuropathology Institute of Neuropathology, University Medical Center Hamburg-EppendorfDirección de correo verificada de uke.de
